Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial.

Abstract

A short course of adalimumab in patients with severe acute sciatica significantly reduces the need for back surgery.

Full Text

DOI - Annals of the rheumatic diseases (DOI)
Ovid Technologies, Inc. - full-text online
Lippincott Williams & Wilkins - full-text online
HighWire Press - full-text online
EBSCO - full-text online

Subjects

Similar articles

Acute sciatica and progressive neurological deficit secondary to facet synovial cysts: A report of two cases. (2012-09-21)
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial. (2010-08-12)
Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. (2004-08-13)
Safety and efficacy of adalimumab in pediatric patients with Crohn disease. (2008-07-08)
Acute thrombosis of inferior vena cava in a pregnant woman presenting with sciatica: a case report. (2005-02-16)
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. (2005-10-24)
Is there a role for benzodiazepines in the management of lumbar disc prolapse with acute sciatica? (2010-05-18)
Prolonged conservative care versus early surgery in patients with sciatica from lumbar disc herniation: cost utility analysis alongside a randomised controlled trial. (2008-06-16)
Primary and revision lumbar discectomy. A 16-year review from one centre. (2003-08-22)

Authors

Publication date

2012-03-05

Journal

Annals of the rheumatic diseases
Ann Rheum Dis (1468-2060)

Journal topics

Language

Eng.

Copyright

Annals of the rheumatic diseases

Division of Rheumatology, University Hospitals of Geneva, Switzerland. stephane.genevay [at] hcuge.ch

Release reference

Ann Rheum Dis. 2012 Apr;71(4):560-2

Related books

Español | English

© Galenicom 1999-2013